Gemin X has multiple ongoing and planned clinical trials of its drug candidates across a broad range of cancer types as both a single agent and combination therapy.
>>more

Gemin X
Fact Sheet

Download pdf
Updated 02.20.07

Gemin X is developing small molecules that target specialized pathways for cancer, including key regulators in the genesis and progression of cancer.
>>more

Upcoming Events

Molecular Medicine Tri-Conference
San Francisco, CA (March 25-27, 2008)
BIO International Convention
San Diego, CA (June 17-20, 2008)